Bone Biologics Partners with MTF to Supply DBM

Bone Biologics entered into a supply agreement with MTF Biologics for demineralized bone matrix (DBM).

Bone Biologics is developing a bone graft substitute product comprising rhNELL-1 growth factor and a carrier, to be supplied by MTF, for the initiation and improvement of bone formation. This agreement provides material for Bone Biologics'...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us